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Abstract
The p90 ribosomal protein kinase 2 (RSK2) is a highly expressed Ser/Thr kinase activated by growth factors and is involved in
cancer cell proliferation and tumor promoter-induced cell transformation. RSK2 possesses two non-identical kinase
domains, and the structure of its N-terminal domain (NTD), which is responsible for phosphorylation of a variety of
substrates, is unknown. The crystal structure of the NTD RSK2 was determined at 1.8 A ˚ resolution in complex with AMP-PNP.
The N-terminal kinase domain adopted a unique active conformation showing a significant structural diversity of the kinase
domain compared to other kinases. The NTD RSK2 possesses a three-stranded bB-sheet inserted in the N-terminal lobe,
resulting in displacement of the aC-helix and disruption of the Lys-Glu interaction, classifying the kinase conformation as
inactive. The purified protein was phosphorylated at Ser227 in the T-activation loop and exhibited in vitro kinase activity. A
key characteristic is the appearance of a new contact between Lys216 (bB-sheet) and the b-phosphate of AMP-PNP.
Mutation of this lysine to alanine impaired both NTDs in vitro and full length RSK2 ex vivo activity, emphasizing the
importance of this interaction. Even though the N-terminal lobe undergoes structural re-arrangement, it possesses an intact
hydrophobic groove formed between the aC-helix, the b4-strand, and the bB-sheet junction, which is occupied by the N-
terminal tail. The presence of a unique bB-sheet insert in the N-lobe suggests a different type of activation mechanism for
RSK2.
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Introduction
The 90-kDa ribosomal S6 kinase 2 (RSK2) is a serine-threonine
kinase, which plays a key role in the mitogen-activated protein
(MAP) kinase signaling pathway. RSK2 is activated in response to a
variety of stimuli, including insulin, growth factors, neurotransmit-
ters, and chemokines [1]. The RSK2 pathway is a key regulator of
cancer cell proliferation [2–4]. RSK2 phosphorylates a variety of
substrates, including the cAMP-responsible element-binding 2
protein [5], histone H3 [6], the tumor suppressor p53 protein [7],
cell cycle proteins Myt1 [8] and Bub1 [9], transcriptional factors
including c-Fos [10,11], activating transcriptional factor-4 [12], and
nuclear factor of activated T cell [13].
In mammals, the RSK family comprises four closely related
isoforms, RSK1-4. RSK and MSK (mitogen- and stress-activated
protein kinase) constitute a family of protein kinases that mediate
signal transduction downstream of the MAP kinase cascades.
Among the many serine-threonine kinases, only two unique kinases,
RSK and MSK, contain two distinct kinase domains in a single
polypeptidechain,separatedbyalinkerregionof,100aminoacids
[14]. Both domains are catalytically functional [15], and the C-
terminal kinase domain (CTD) regulates the activity of the N-
terminal domain (NTD) through phosphorylation of the hydropho-
bic linker region. The current mechanism of activation of full length
RSK2 is suggested to occur through the activation of theC-terminal
protein kinase domain by its interaction with and phosphorylation
by ERK1/2 [16–18]. The activated CTD RSK2 autophosphor-
ylatesSer386inthelinkerregion[19],whichbecomes adockingsite
for PDK1 [20] that activates the NTD RSK2 through phosphor-
ylation of Ser227 in the T-activation loop [21].
The crystal structure of the C-terminal protein kinase domain
(CTD) RSK2 was recently solved in our laboratory [22]. The
structure of the RSK2 full length protein or the separate RSK2 N-
terminal domain, which is responsible for phosphorylation of
different endogenous substrates, is still unknown. The crystal
structure of the N-terminal domain of a close homologue, MSK1,
was reported in its inactive conformation with a distorted nucleotide
binding loop that occluded the ATP binding site [23]. The authors
suggested that an inactive MSK1 NTD conformation is stabilized
by a newly formed three-stranded b-sheet in the N-terminal lobe.
The activation mechanism of the MSK1 NTD was proposed to
occur through a transition from the bB-sheet insert to the aB-helix.
The recently published NTD RSK1 structure (residues 56–340)
showed a disordered N-terminal end, T-activation loop, and aC-
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complex with an ATP analogue and two inhibitors, staurosporine
and purvalanol A, the authors indicated that the structural
conformation of RSK1 was inactive because the ATP analogue
was bound in an orientation not favorable for phospho-transfer
and the protein was also catalytically inactive in solution.
The NTD RSK2 is thought to belong to the growth factor-
activated AGC superfamily of kinases (protein kinase A/protein
kinase G/protein kinase C), which have the kinase domain
followed by the C-terminal hydrophobic motif (HM) tail.
Phosphorylation of the hydrophobic motif residues in combination
with phosphorylation of the T-loop results in the synergistic
activation of AGC kinases [25–28]. Among others, the AGC
family includes the cAMP-dependent protein kinase (PKA), Akt
(PKB), protein kinase C (PKC), and 3-phosphoinositide-dependent
protein kinase-1 (PDK1). The nonphosphorylated, inactive PKB
possesses a completely disordered aC-helix [26]. A structural study
of the activated PKB showed that the phosphorylated HM
occupies a hydrophobic motif pocket formed at the N-terminal
lobe, leading to the ordering of the aC-helix and stabilization of
the kinase active conformation [29]. PDK1, the master regulator
of AGC kinase signal transduction, activates its substrates by
phosphorylation of the T-activation loop. PDK1 is an atypical
AGC member because it does not possess the characteristic
hydrophobic C-terminal tail. The region of PDK1 that interacts
with the phosphorylated HM of its substrates is located at the same
pocket at the N-lobe of the catalytic domain [30–32]. Neither the
N-terminal kinase domain of the MSK1 or RSK1 structure
showed localization of the C-terminal hydrophobic tail or the
presence of the aB-helix, a secondary element that is usually
located in the N-lobe of AGC-kinases. The absence of the C-
terminal extension in the protein constructs and the absence of the
aB-helix in the crystal structures of RSK1 and MSK1 were
proposed as additional reasons for the enzyme inactivity [23,24].
The available physiological data imply that the N-terminal
protein kinase domain of both RSK and MSK is involved in the
phosphorylation of a variety of substrates, and is believed to have
an active kinase conformation. Unexpectedly, the crystal structures
of MSK1 and RSK1 exhibited the inactive conformation. Herein,
we present an analysis of the refined high-resolution structure of
the isolated recombinant N-terminal protein kinase domain (NTD)
of RSK2 in the active conformation complexed with an ATP
analogue. The kinase activity was confirmed by a complimentary
enzyme assay.
Results and Discussion
Overall Structure
The X-ray crystal structure of the N-terminal kinase domain of
RSK2 (residues 44–367) complexed with AMP-PNP was refined to
1.8 A ˚ resolution. The structure was solved by molecular
replacement using the available NTD MSK1 (residues 24–345)
structure as a search model (PDB code 1VZO). At the time of our
structure determination, the coordinates for NTD RSK1, which
are now available (PDB code 2Z7Q) in the protein data bank,
were not yet released. The final RSK2 model has an R-factor
equal to 20.4% and R-free equal to 24.8% with good
stereochemistry. The unit cell parameters, details of data
collection, and refinement statistics are presented in Table 1.
The NTD RSK2 adopted an overall protein kinase two-lobal
scaffold with the ATP-binding site in the cleft between the small
N-terminal lobe and large a-helical C-terminal lobe (Figure 1).
The protein was concentrated and crystallized in the presence of a
non-hydrolyzable ATP analogue, AMP-PNP, which was easily
recognized in the electron density map inside the active site. The
T-activation loop (residues 220–230), part of the aC-helix (residues
111–119), and the N- and C-termini (residues 44–46 and 347–367,
respectively) were not visible in the electron density map and were
not included in the current model.
The refined NTD RSK2 structure showed an overall similar
structure with NTD MSK1, including an unusual bB-sheet insert
in the N-terminal lobe (Figure 1, 2A). Two kinase structures are
superimposed with a root mean square deviation (r.m.s.d.) of
1.46 A ˚ for the corresponding Ca atoms. The available crystal
structure of NTD RSK1 did not provide any insight as to whether
the bB-sheet insert exists in the N-lobe, because the purported bB-
sheet residues are mostly located in the disordered region of the
RSK1 structure. A two-structure superimposition showed that the
N-lobe of RSK1 has enough room for the bB-sheet to be inserted
without too many steric clashes (Figure 2B).
NTD RSK2 Is Active In Vitro
We were interested to determine whether the isolated NTD
RSK2 protein had kinase activity. The NTD RSK2 with the
truncated hydrophobic linker (residues 1–360) was phosphorylated
by PDK1 at Ser 227 in the T-activation loop, which resulted in
increased activity toward the S6 peptide ex vivo and in vitro [21].
Taking advantage of this fact, we performed an in vitro kinase assay
Table 1. X-ray data collection and refinement statistics
a).
Data collection
Space group P212121
Cell dimensions
a, b, c (A ˚) 51.17, 51.38, 140.87
Resolution
b) (A ˚) 36-1.8 (1.86-1.80)
Rmerge 0.091 (0.89)
Rp.i.m.
c 0.041 (0.39)
I/s 15.2 (2.0)
Completeness (%) 99.4 (94.8)
Redundancy 6.2 (5.0)
Refinement
Resolution (A ˚) 36-1.8
No. reflections 32826
Rwork/Rfree
d 0.204/0.248
No. atoms
Protein 2518
AMP-PNP 31
Water 274
B-factors (A ˚2)
Protein 31.0
AMP-PNP 26.3
Water 35.6
R.m.s. deviations
Bond lengths (A ˚) ,0.003 A ˚
Bond angles (u) ,0.6 A ˚
a)One crystal was used for the structure determination.
b)Highest resolution shell is shown in parenthesis.
c)Precision-indicating merging R factor.
d)Rfree was calculated from a randomly chosen 5% of reflections excluded from
refinement.
doi:10.1371/journal.pone.0008044.t001
Structure of NTD RSK2
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without activation by PDK1 and a biotinylated S6 peptide.
Surprisingly, the isolated NTD RSK2 displayed in vitro kinase
activity toward the S6 peptide even without activation by PDK1
(Figure 3). To determine why NTD is active, we performed
Western blot analysis that showed that Ser 227 was phosphory-
lated in the purified protein (Figure S1). Pre-incubation of NTD
with active PDK1 for 10–20 min increased the enzyme activity 1.5
– 3 fold most likely because of additional phosphorylation of the
partially phosphorylated NTD fragment. The crystallized protein
was also phosphorylated at Ser 227 as shown by Western blot. The
T-activation loop region, including that serine residue, was
disordered in the current structure.
The ATP-Binding Site
The AMP-PNP molecule was modeled into a well-defined
electron density in the NTD RSK2 active site. The omit electron
density map showed a continuous electron density perfectly
covering the adenine, sugar, and phosphate groups. The detailed
interaction of AMP-PNP with the active site amino acid residues is
presented in Figure S2, which was generated by Ligplot [33]. We
checked the position of all the conserved residues in the ATP-
binding pocket and compared them with corresponding residues in
active PKA and inactive RSK1 or MSK1. The superimposition of
the ATP-binding site of the NTD RSK2 and active PKA is
illustrated in Figure 4A. The overall hydrogen bonding network
between the AMP-PNP molecule and invariant amino acid residues
in the RSK2 catalytic site is similar to that of PKA, which is optimal
for phosphotransfer [34–37]. The conserved Lys100 from the b3-
strand, a crucial residue responsible for correct alignment of ATP
phosphates for catalysis, coordinates a- and b-phosphate groups
and occupies a position similar to Lys72
PKA. Another conserved
residue, Asn198 of NTD RSK2 (analogue Asn171
PKA), located on
the catalytic loop, forms two hydrogen bonds with a- and c-
phosphates (distance 2.79 A ˚ and 3.11 A ˚, respectively). All other
conserved residues from the DFG-motif (residues 211–213) and the
RD-motif (residues 192–193) have a similar conformation to the
corresponding residues of PKA, as clearly seen in Figure 4A.
When comparing the RSK2 structure with inactive RSK1 and
MSK1, the positions of some of the conserved residues are
different (Figure 4B and 4C). The catalytically inactive NTD
RSK1 forms a nonproductive complex with ATP as was described
previously [24]. The conformational position of the three
phosphate groups and ribose ring moiety was not aligned properly
for phosphotransfer (Figure 4B). Displacement of the ATP
molecule from its proper position does not allow the conserved
Lys94
RSK1 from the b3-strand (analogue of Lys100
RSK2)t o
coordinate the phosphate groups in the RSK1 structure. Instead,
Lys94
RSK1 forms a hydrogen bond with an aspartate (DFG-motif),
a position that differs from Asp211
RSK2.
The conformation of the phosphate-binding loop in MSK1
prevents the binding of ATP as was described [23] and
demonstrated in Figure 4C. The side chain of Tyr60
MSK1
occludes the adenosine moiety binding. Deformation of the P-
loop most likely resulted in the misalignment of a crucial Lys81
MSK1 from the b3-strand. Lys81
MSK1 is rotated ,90u compared
to the analogue Lys100
RSK2 and forms a hydrogen bond with the
b2-strand of the P-loop. We conclude that the distortion of the
phosphate-binding loop and consequent blockage of the ATP
binding site by the side chain of Tyr60 is a primary reason for
MSK1 inactivity. Superimposition of the active sites of the N-
terminal domains of RSK2 and MSK1 clearly showed no
deformation of the P-loop in RSK2, which is arranged properly
allowing a productive binding of ATP in the active site pocket.
The conformation of all other conserved residues from the DFG-
motif (residues 211–213), RD-motif (residues 192–193), and
catalytic Asp198 in the RSK2 structure closely resembles that
observed in MSK1.
Figure 1. A ribbon diagram of the NTD RSK with two views rotated by 90u. The b-strands are shown in green, the a-helices are in cyan, and
the coils are shown in yellow. The AMP-PNP molecule is shown in sticks presentation and colored magenta. The new bB-sheet insert is indicated by
the arrow.
doi:10.1371/journal.pone.0008044.g001
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The N-lobe of the NTD RSK2, traditionally composed of
twisted, five stranded b-sheets, has a new intriguing feature. The
novel bB-sheet, unusual for most kinases, was inserted into the N-
lobe (Figure 1). The bB-sheet insert is comprised of three
antiparallel b-strands: the b-1-strand (residues 48–52) at the N-
terminal end; the novel bB-strand (residues 104–109); and the b9-
strand of the activation segment (residues 215–217). Within the N-
lobe, three b-strands were well defined in the electron density map
(Figure 5). Threaded together by the hydrogen bond network,
three b-strands comprise the stable bB-sheet. The N-terminal b-1-
strand, which is outside of the protein kinase domain and
harmonically embedded in the kinase fold, forms several hydrogen
bonds with the middle bB-strand. The b9-strand, an element of
the activation segment, is turned upward, and hydrogen bonded
with the bB-strand as well.
A similar bB-sheet insertion in the N-terminal kinase lobe was
previously observed in the NTD MSK1, and was suggested to
stabilize its inactive conformation [23]. Our comparison of the
active site of the ATP-bound RSK2 with the non-ATP-bound
MSK1 structure (Figure 4C) clearly illustrates that distortion of the
correct position of the phosphate-binding loop and consequent
occlusion of ATP binding by Tyr60
MSK1 was not due to insertion of
the bB-sheet into the N-lobe. We showed that the presence of the
bB-sheet in the NTD RSK2 does not impair the ability of the
enzyme to exhibit phosphotransferase activity (Figure 3) or to bind
strongly with ATP in the crystal form (Figures 1, 4). Rather, we
suggest that a new bB-sheet insert, instead of the aC-helix, stabilizes
the N-terminal kinase lobe active conformation. In the NTD RSK2
structure, the aC-helix is pushed away from its regular position by
the bB-sheet (Figure 1), and consequently, the conserved Glu118
residue (invisible in the structure) from the aC-helix cannot interact
with Lys100. Despite the absence of a salt bridge, the N-lobe
maintains its integrity by the appearance of the new bB-sheet.
Involvement of Lys216 in Phosphate Binding
Examination of the active site revealed a Lys216 residue
engaged in ATP binding (Figures 4C, 6A). The lysine, located on
the bB-sheet, interacts with the b-phosphate (distance 2.66 A ˚) and
the conserved Asp211 (distance 2.86 A ˚) from the DFG-motif. The
Lys216 occupies a central position in the deep cavity formed inside
the N-lobe. The hydrophobic cavity is lined by Leu214, Leu102,
and Phe212 and is shielded by the side chain of Phe79 from the P-
loop (Figure 6A). Similarly, in PKA, the cavity is lined by Phe187,
Leu74, Phe185, and Phe54 (Figure 6B). The Glu91
PKA introduces
Figure 2. Superimposition of the N-terminal kinase domain of
RSK2 with the similar domain of MSK1 (A) or RSK1 (B). The NTD
RSK2 is shown in cyan in both (A) and (B). The inactive NTD MSK1 (PDB
code 1VZO) is shown in yellow (A) and the inactive NTD RSK1 (PDB
code 2Z7Q) is shown in red (B). The ATP molecule from the RSK1
structure is omitted. Obviously, the disordered region in RSK1 may
accommodate the bB-sheet.
doi:10.1371/journal.pone.0008044.g002
Figure 3. The NTD RSK2 exhibits intrinsic kinase activity. The
protein was incubated with a biotinylated S6 peptide and [c-
32P] ATP
for 60 min at 30uC. Where indicated, the protein was pre-activated by
active PDK1 for 10 min. The radiolabeled, phosphorylated S6 peptide
was recovered from the reaction mixture by biotin capture membrane.
The contribution of PDK1 to S6 peptide was negligible.
doi:10.1371/journal.pone.0008044.g003
Structure of NTD RSK2
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PKA.
The lack of a glutamic acid residue (Glu118 from the aC-helix) in
RSK2 due to disruption of the Lys-Glu salt bridge creates a void of
charges, and Lys216 compensates by introducing a positive charge
to the hydrophobic cavity. A comparison with PKA illustrates that
Lys216 may ‘‘substitute’’ for the displaced Glu118 (Glu91
PKA)
residue, even though they have different charges. Instead of the
salt bridge, Lys100-Glu118, a new mode of connection appeared –
Lys100-b-phosphate-Lys216. The internal volume of the ATP-
binding site in the NTD RSK2 is slightly larger (1130 A ˚)
compared with PKA (1115 A ˚) due to a secondary structure re-
arrangement (appearance of the bB-sheet).
Mutation of Lys216 Supports Its Role
The involvement of one more residue, in addition to Lys100
from the b3-strand, for the coordination of the b-phosphate
comprises a novel binding contact never before seen in other
kinases complexed with ATP. The corresponding Lys200 residue
in the apo form NTD MSK1 occupies a similar conformation
(Figure 4C) and contacts an aspartate residue from the DFG-motif
as well. However, without an ATP bound in the active site and a
distorted phosphate-binding loop, to predict the importance of
that lysine residue in MSK1 was difficult.
To determine whether Lys216 actually participates in phos-
phate binding or whether its position is a crystal artifact, we
mutated Lys216 to alanine to prevent the interaction introduced
by Lys216. We expected that the mutation would have an effect on
substrate phosphorylation if the Lys216 facilitates ATP binding.
An in vitro kinase assay using [
32P]ATP and a biotinylated S6
peptide showed that the K216A mutant exhibited an impaired
functionality compared with wildtype at all measured time points
(Figure 7A). Stimulation of the mutant K216A NTD with PDK1
enhanced protein activity in a manner similar to wildtype
(compare Figure 7B and Figure 3). The Western blot showed an
approximate equal level of phosphorylation at Ser227 for the two
proteins (Figure S1). We assume that the observed reduction of
approximately 30% in activity was a result of the mutation.
To determine whether the wt NTD or K216A mutant might
autophosphorylate itself thereby increasing its intrinsic activity, we
performed a luminescent kinase assay. The assay measures the
amount of ATP remaining in solution following a kinase reaction
and allows a comparison of the effective doses for wild type and
mutant (Figure 7C). Serial two-fold dilutions of protein were made
across a 96-well plate in 50 ml buffer containing the S6 peptide. The
kinase reaction was started by addition of ATP, carried out for 60
minutes at room temperature, and terminated by adding the
luminescent Kinase-Glo
H Reagent. The wildtype and K216A
mutant showed a different capability to phosphorylate the S6
peptide and neither exhibited an autophosphorylation activity. The
effective concentrations (EC50) calculated from the curves for NTD
wt and the K216A mutant were 1.460.2 mg and 1.960.1 mg,
respectively. The result shows that a higher amount of mutant is
required to reach 50% maximal response. The slightly, but not
dramatically, reduced enzyme activity of the K216A mutant
indicates that a single point mutation did not introduce global
conformational changes into the N-lobe, and confirmed the
structural finding that Lys216 participates in phosphate binding.
To explore the role Lys216 mutation in RSK2 activity ex vivo,
we performed a 36NFAT-luciferase reporter gene assay with wild
type full length RSK2 and the K216A mutant. The 36NFAT-
luciferase activity was increased in a dose-dependent manner by
the presence of wild type RSK2 as was previously reported [13].
However, the RSK2 K216A mutant exhibited impaired activity as
compared with wild type at all different concentrations (Figure 8).
The ex vivo mutation data are consistent with the reduced activity
observed in the K216A mutant in vitro.
Implications of NTD RSK2 Structural Diversity
A set of four structural modulations classifies a protein kinase in
an ‘‘inactive’’ conformation [38,39]. The modulations include the
distortion of the glycine-rich loop, blockage of the ATP binding
site, and activation segment conformation and displacement of the
aC-helix. The first two modulations were observed in the NTD
MSK1, as described above, and resulted in protein inactivity. A
Figure 4. A comparison between the active sites of NTD RSK2 and active PKA (A), inactive NTD RSK1 (B), and inactive NTD MSK1
(C). RSK2 is shown in cyan in all panels, and only the residues of RSK2 are labeled. The active site cleft is shown with approximately the same view
and zoom. (A) Active PKA (PDB code 1ATP) is shown in blue. The AMP-PNP molecule (magenta sticks) is depicted only from the RSK2 structure and is
omitted from the PKA structure for simplification (because of a nearly overlapping conformation). The positions of most of the conserved active site
residues of RSK2 are similar to those of active PKA. Those residues are Lys100 of RSK2 and Lys72
PKA located on the b3-strand; Asn198 and Asn171
PKA
from the catalytic loop; Asp211 (DFG-motif) and Asp184
PKA; and Asp193 (RD-motif) and Asp166
PKA.( B) The inactive NTD RSK1 (PDB code 2Z7Q) is
shown in red with the bound ATP molecule shown in blue. The overall view is rotated by ,10u about the vertical axis relative to panels (A) and (C) to
show the difference in orientation of the ribose ring and phosphate groups. Lys94
RSK1, an analogue of the Lys100
RSK2 residue, does not interact with
the phosphate group and forms a hydrogen bond with the Asp205 from the DFG-motif. Asp205
RSK1 occupies a different position compared with
Asp211
RSK2.( C) The inactive NTD MSK1 (PDB code 1VZO) is shown in yellow. The position of the glycine-rich loop (P-loop) is distorted in the MSK1
structure. As a result, Tyr60
MSK1 (blue) occludes the binding of the ATP molecule. A lysine from the b3-strand, Lys81
MSK1, is oriented perpendicularly
compared with Lys100
RSK2 and forms an H-bond with the P-loop. Lys216
RSK2 and Lys200
MSK1 from the b9-strand occupy the same position.
doi:10.1371/journal.pone.0008044.g004
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conformations of two structural elements, the activation segment
(DFG-motif) and the aC-helix, revealed three discrete clusters
[40]. Two clusters included inactive kinases with a DFG-out
conformation and an aC-helix-out (displaced) conformation.
Structures with displaced aC-helices account for 17% of the
structures available. A key characteristic of the active conforma-
tion of most known kinases is a strong ionic interaction between a
positively charged lysine from the b3-strand and a negatively
charged glutamic acid from the aC-helix [34,38–40]. By linking
the aC-helix to the b3-strand, the lysine-glutamate salt bridge also
helps to stabilize the overall fold of the N-terminal lobe [41]. The
appearance of the bB-sheet insert in the N-lobe of the NTD RSK2
resulted in the displacement of the aC-helix and disruption of the
Lys-Glu interaction, but, nevertheless, the protein exhibited
enzyme activity in solution. We present a kinase structure that
would be classified as having an ‘‘inactive’’ conformation (the
displaced aC-helix), but is actually an active phosphorylated kinase
confirmed by complementary protein activity assay.
The aC-helix anchored by a conserved salt bridge toward the
N-lobe is known as an important mediator of conformational
changes in some protein kinases of the CDK and Src families.
They are activated by the movement of the aC-helix from a
‘‘displaced’’ to ‘‘active’’ conformation [42,43]. In the absence of
the activator cyclin, the aC-helix of the CDK2 is rotated outward
and the lysine-glutamate ionic pair is disrupted, albeit ATP is
bound in the active site [44]. Cyclin binds directly to the aC-helix
promoting its inner rotation and restoring the Lys-Glu interaction
[45,46]. The intramolecular interactions of the Src SH3 or SH2
domain with its kinase domain promote the displacement of the
aC-helix and disruption of the lysine-glutamic acid ionic pair
[43,47]. Ligand binding to SH3 and SH2 domains activates Src
family kinases allowing re-positioning of the aC-helix to the active
conformation [48–50]. The available crystal structures of other
protein kinases in both the inactive and active states showed that
the aC-helix is not always the key regulator of activity. For
example, the ‘‘aC-helix displacement’’ is not an element of focal
adhesion kinase (FAK) regulation because the position of the aC-
helix is not changed upon activation [51]. Moreover, the proposed
structural coupling between the aC-helix and the T-activation
loop does not always occur. The integrity of the aC-helix of PDK1
is not regulated by the T-activation loop phosphorylation [52].
Displaced aC-helix-out conformation in the crystal structure of
NTD RSK2 is not equated with lack of protein activity. We believe
that the bB-sheet insert compensates for the aC-helix displacement
by playing a stabilization role and directing the Lys216 residue
toward the active site. Others have reported [23], that upon enzyme
activation, the bB-insert of the NTD MSK1 undergoes a structural
transition resulting in the appearance of the aB-helix. For this
conformational rearrangement, a stable bB-sheet composed of a triad
of b-strands should be disrupted first, the two bB-strands would swing
apart, and the middle bB-strand must be unfolded and refolded to
form a novel aB-helix. Phosphorylation of the T-activation loop in
our crystallized NTD RSK2 fragment did not induce those supposed
structural rearrangements. However, we cannot exclude the
possibility of the bB-sheet unfolding and restoring the aC-helix
position and the Lys-Glu ionic interaction in vivo. The bacterially
expressed E118A NTD mutant was not phosphorylated at Ser227
(FigureS1) and was not active. Whether the activity loss was the result
of non-phosphorylation or the mutation of the Glu118 residue is not
clear, and we conclude that Glu118 still might be an important
mediator of the re-arranged conformation.
The role of the bB-sheet insert is fascinating and needs to be
elucidated. This type of insertion in the N-terminal lobe kinase
scaffold has never been observed in the kinase domains of other single
protein kinases. We believe that this might be a unique feature of two
particular kinases, RSK and MSK, which are dual kinases that have
two protein kinase domains in a single polypeptide chain. We suggest
that the insert might be involved in the correct scaffolding of the full
length protein, and might serve as an intermediate structural element
connecting the N-terminal kinase domain with the linker region and/
or the C-terminal kinase domain. An unusual insert might also be a
structural element that is required for synergistic protein activation in
a uniquely different regulatory mechanism of dual kinases. The
crystal structure of the full length RSK2 or MSK1 might provide
insights as to whether the bB-sheet undergoes structural rearrange-
ment and its role in the full length protein.
The N-Terminal Lobe Groove
The N-terminal lobe has a deep groove on the surface between
the aC-helix and the b4-strand junction with the bB-sheet
(Figure 9A). Even though the aC-helix is partially disordered in
the crystal structure, the groove is clearly defined. We superimposed
the structure of the NTD RSK2 with PKB and found that the N-
lobe groove is similar to that of PKB (Figure 9B). The groove is
Figure 5. The electron density from the final 2Fo-Fc map for
the bB-sheet insert. The bB-sheet insert consists of three b-strands: b-
1, bB, and b9-strands, which are held together by the hydrogen
bonding network. The hydrogen bonds between the strands are shown
as dotted lines. Oxygen atoms are in shown in red, nitrogen atoms are
in blue, and carbons in green. The lysine 216 residue located on the bB-
strand is labeled.
doi:10.1371/journal.pone.0008044.g005
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groove of NTD RSK2 is lined with more hydrophobic residues
compared with PKB.WhereasinPKBthisregionis occupied bythe
C-terminal hydrophobic motif (HM), in the NTD RSK2, the N-
terminal b0-strand (residues 55–57) is anchored to that groove by
several hydrogen bonds with the b4-strand. Superimposition of two
structures showed that the position of the b0-strand of the NTD
RSK2 and the HM of PKB are perfectly overlapped.
The aC-helix, which forms one side of the N-lobe pocket, is not
completely ordered in the current structure, and we suggest that the
groove might have a different depth due to the ordering of the aC-
helix. The N-terminal end appears to play a stabilization role for the
isolated NTD RSK2 fragment, which did not have the hydrophobic
motif C-terminal end. Similar to our structure, the N-terminal tail
occupied a comparable hydrophobic motif groove in the N-lobe in
the recently published structure of serum and glucocorticoid-
regulated kinase 1 (SGK1), which is also an AGC kinase [53].
Whether the N-terminal end of the full length protein will flip away
from the groove allowing the acquisition of the hydrophobic motif
linker region, or whether the phosphorylated HM will form the b-
sheet with the b0-strand is unknown. The bB-sheet structure might
possibly be disrupted if the HM-region displaces the b0-strand that is
adjacent to the b1-strand, which contributes in the novel bB-insert.
Materials and Methods
Protein Purification and Crystallization
Eighteen N-terminal kinase domain (NTD) fragments of
different lengths of mouse RSK2 were cloned into E.coli using a
full length cDNA clone. Most of the fragments with high-level
expression were purified, but failed to crystallize. Longer
constructs including the hydrophobic linker region had low
solubility and poor yield. Only one construct of the NTD (residues
44–367) produced crystals. The protein was cloned into NdeI/
HindIII restriction sites of the pET-28a vector (Novagen). The
recombinant His-fusion NTD RSK2 was expressed in E.coli BL21-
Codon Plus (DE3)-RIPL competent cells (Stratagene). The cells
were harvested after an additional 5 h of growth at 25uC following
induction with 0.2 mM isopropyl-beta-D-thiogalactopyranoside.
The cell pellet was resuspended in 30 ml of washing buffer
(30 mM imidazole, 500 mM NaCl, 50 mM NaH2PO4, pH 8.0,
10% glycerol, 10 mM b-mercaptoethanol). Cells were disrupted
by French Press (Thermo Electron Co.) and clarified by
centrifugation. Soluble His-tagged NTD RSK2 was eluted from
nickel-nitrilotriacetic acid agarose (Qiagen) with buffer that
contained increasing concentrations of imidazole (100 mM and
200 mM), 150 mM NaCl, and 20 mM Tris pH 8.0. All eluted
fractions were combined and diluted in the same buffer without
imidazole to prevent protein precipitation. The protein was
purified further by size exclusion chromatography on a HiLoad
16/60 Superdex-200 column (GE Healthcare) equilibrated with
buffer (150 mM NaCl, 20 mM Tris pH 8.0). We were able to
concentrate the protein only when the non-hydrolyzable ATP
analogue, adenosine 59-(b,c-imido)triphosphate tetralithium salt
hydrate, AMP-PNP (Sigma-Aldrich), was added to the protein
solution during the concentration step. The final protein stock
solution at a concentration of 10–15 mg/ml contained 2 mM
Figure 6. The hydrophobic patch and role of Lys216. The stereo view of the hydrophobic patch formed deep inside the N-lobe and lined by
hydrophobic residues is shown for NTD RSK2 in cyan (A), and in blue for PKA (PDB code 1ATP) (B). The AMP-PNP molecule is shown in magenta.
Lys216, located on the b9-strand of the activation segment and interacting with the b-phosphate and Asp211, introduces a charge to the cavity
similar to Glu91
PKA.
doi:10.1371/journal.pone.0008044.g006
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different concentrations (2.5 mg/ml–10 mg/ml) was mixed at a
2:1 ratio with precipitant solution (6%–10% PEG 3350, 0.2 M
proline, 0.1 M Hepes pH 7.5). The crystals were grown at 20uC
by the sitting drop vapor diffusion method within 1–2 days. The
mutant proteins, K216A and E118A, also had high expression
yield and were purified by similar procedures.
Data Collection and Structure Determination
The crystals were flash-cooled in liquid nitrogen after a short soaking
in cryo-protection solution (15% PEG 3350, 0.2 M proline, 0.1 M
Hepes pH 7.5, 20% glycerol). The high-resolution data sets were
collected at the Advanced Photon Source (APS) microdiffraction
b e a m l i n e2 4 I D - Eu s i n ga2 0m i c r o nb e a m .T h ef u l ld a t as e tw a s
collected from three portions of the elongated rod-like crystal. The
crystal-to-Quantum 315 CCD detector distance was 250 mm and the
crystal was rotated around the spindle axis with images collected over
160u to a resolution of 1.7–1.8 A ˚. Data were integrated and scaled
using the HKL2000 package [54]. The real resolution of the data, used
for structure refinement, was estimated taking into consideration the
completeness of the last resolution shell, I/s ratio and R-merge values.
RSK2 crystals belong to the primitive orthorhombic lattice with one
molecule in the asymmetric unit cell. The atomic coordinates of the
refined MSK1 structure (PDB code 1VZO) were used for the initial
crystallographic phasing by molecular replacement. All calculations
were performed using PHENIX [55]. With the model given by
molecular replacement, a rigid body refinement was carried out at
3.5 A ˚ resolution. All data with a high-resolution limit of 1.8 A ˚ were
used for structure refinement. Once a satisfactory description of the
protein electron density was complete, water molecules and AMP-PNP
were added. A few cycles of slow-cooling annealing (5000R100 K),
positional and restrained isotropic temperature factor refinements were
followed by visual inspection of the electron density maps, including
omit maps, coupled with manual model building (when necessary)
using the graphics program COOT [56]. The refined electron density
clearly matched the amino acid sequence of RSK2 with the exception
of the N- and C-termini (residues 44–46 and 347–367) and two
disordered loops 111–119 and 220–230. Strong stereochemical
Figure 7. Comparison of wildtype NTD and K216A mutant phosphotransferase activity. (A) The K216A mutant showed a reduction of
approximately 30% in activity toward the S6 peptide compared with wildtype. A kinetics assay was performed with a biotinylated S6 peptide and
[c-
32P] ATP as described in Materials and Methods. (B) Pre-incubation with active PDK1 for 10 min stimulated K216A kinase activity about two fold in
a similar pattern as the wildtype protein. (C) Kinase-Glo
H luminescent kinase assay. The kinase titration was performed in the presence of ATP and the
S6 peptide. Control experiments with ATP alone (no protein, no substrate) or ATP with protein (no substrate) are shown. Neither of proteins showed
autophosphorylation activity. The control experiment with only substrate (no protein) showed the same luminescent signal as ATP alone and is not
shown in the graph. All experiments were reproduced several times.
doi:10.1371/journal.pone.0008044.g007
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final RSK2 structure possessed a very good stereochemistry. The
r.m.s.d. between two molecules before and after the final round of
refinement was less than 0.05 A ˚. The quality of the stereochemistry of
the final protein structure was assessed with the PROCHECK package
[57]. The Ramachandran plot showed no residues in generously
allowed or disallowed regions (data not shown). As a better guide to the
quality of the structure, the values of the free R-factor were monitored
during the course of the crystallographic refinement. The final value of
free R-factors did not exceed the overall R-factor by more than 5%.
Rp.i.m, precision-indicating merging R factor, was calculated as
described [58]. Structural figures and graphical rendering were made
using PYMOL (http://pymol.sourceforge.net). The volume calcula-
tions were performed with the program CASTp [59].
In Vitro [c-
32P]ATP Kinase Assay
For an in vitro kinase assay, the recombinant His-fusion NTD
RSK2 (residues 44–367) wildtype and K216A mutant that were
purified on a HiLoad 16/60 Superdex-200 column at a protein
concentration of 0.5–0.7 mg/ml without the addition of AMP-PNP.
A biotinylated S6 peptide, biotin-AKRRRLSSLRA (AnaSpec) was
used as a substrate. One mg of NTD (wildtype or K216A mutant) was
mixed with 5 mg biotinylated S6 peptide, 1 mCi [c-
32P]ATP,100 mM
ATP in kinase buffer, and incubated for 60 min at 30uC. Total
reaction volume was 25 ml. Kinase buffer (Cell Signaling) included
25 mM Tris pH 7.5, 5 mM b-glycerophosphate, 2 mM dithiothre-
itol, 0.1 mM Na3VO4, and 10 mM MgCl2.T os h o wa c t i v a t i o nw i t h
PDK1, the wildtype NTD RSK2 and K216A mutant were pre-
incubated with 0.1 mg active PDK1 (Millipore) for 10 min at 30uCi n
the presence of the ATP mixture. Reaction aliquots (25 ml) were
taken as duplicates from the tubes at different time points and added
to 7.5 M guanidine hydrochloride (12.5 ml) to terminate the kinase
reaction. All required negative controls were performed. Reaction
mixture (20 ml) was applied to a SAM Biotin Capture Membrane
(Promega Corp.). Membrane washing was performed according to
the manufacturer’s protocol with 2 M NaCl and 2 M NaCl/1.0%
phosphoric acid solutions. The results were analyzed by scintillation
counter. Kinetics experiments with the wild type NTD and the
K216A mutant were performed under similar conditions.
Luminescent Assay
The Kinase-Glo
H Luminescent Assay (Promega Corp.) was
performed in a solid white, 96-well plate in 50 ml reaction
according to the manufacturer’s instructions. The kinase reaction
conditions were optimized with respect to the amount of ATP and
kinase substrate as recommended. Serial two-fold dilutions of the
Figure 8. Mutation of Lys216 results in inhibition of full length
RSK2 activity ex vivo. Wildtype RSK2 induced NFAT3 activity in a
dose-dependent manner. K216A mutant showed reduced activity. The
36NFAT-luciferase reporter plasmid was co-transfected with pcDNA3-
Flag-NFAT3, pcDNA4-RSK2, or pcDNA4-RSK2-K216A plasmids into HEK
293 cells. The firefly luciferase activity was analyzed after 36 h and
normalized against Renilla luciferase activity. Data are presented as the
mean6S.D. of values from triplicate experiments. The differences were
evaluated using the Student’s t-test (*, p,0.05). The equivalent level of
each expressed protein was confirmed by Western blot and shown in
Figure S3.
doi:10.1371/journal.pone.0008044.g008
Figure 9. The N-terminal groove. The groove formed in the N-terminal lobe is shown under a semi-transparent surface representation for RSK2
(A, pink) and for PKB (B, yellow). (A) The deep groove in the N-lobe of RSK2 is formed between the b4-strand and the aC-helix and is occupied by the
N-terminal b0-strand. Secondary elements of the NTD RSK2 are shown in green and blue. (B) The N-lobe pocket in PKB is formed between the b4-
strand and the aC-helix. Secondary elements of the PKB (PDB code 1O6K) are shown in green and yellow. The C-terminal hydrophobic motif (HM) is
located in the groove on the N-terminal lobe.
doi:10.1371/journal.pone.0008044.g009
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across the plate in kinase reaction buffer (40 mM Tris pH 7.5,
20 mM MgCl2, 0.1 mg/ml BSA) containing 0.1 mM ATP and
25 mM S6 peptide (AKRRRLSSLRA) (AnaSpec, San Jose, CA).
The kinase reaction was carried out for 60 minutes at room
temperature and completed by adding 50 ml of Kinase- Glo
H
Reagent. The luminescence signal, which is inversely correlated
with the amount of kinase activity, was recorded on the
Luminoscan Ascent plate reader at 10 minutes after the addition
of the Kinase- Glo
H Reagent. Effective concentrations (EC50
values) were calculated using SigmaPlot2000 software.
Ex Vivo NFAT3 Activity Assay
The assay was performed as previously described [13]. HEK
293 cells (2.0610
4) were seeded into 48-well plates and incubated
with 10% FBS-DMEM for 24 h before transfection. The
36NFAT-luciferase reporter plasmid was transfected with
pcDNA3-Flag-NFAT3, pcDNA4-RSK2 (full length), or the
pcDNA4-RSK2 K216A mutant (full length). The cells were
disrupted after 36 h by the addition of lysis buffer (0.1 M
potassium phosphate buffer pH 7.8, 2 mM EDTA, 1 mM DTT,
1% Triton X-100) and analyzed for firefly luciferase activity using
the Luminoskan Ascent plate reader. The 36NFAT-luc luciferase
activity was normalized against Renilla luciferase activity (pRL-
SV40). The experiments were performed as triplicates and
reproduced twice. To confirm equal transfection efficiency for
the wt RSK2 and mutant, we proportionally increased the amount
of protein (200, 400, and 800 ng) and performed Western blot
analysis.
Western Blotting
Phospho Ser227 antibodies (Cell Signaling) were used with
purified proteins and the crystal. The crystal was washed three
times in the well solution and put in SDS-buffer. The Xpress
antibodies (Invitrogen) were used to visualize RSK2 in HEK293
cells.
Mutagenesis
Point mutations of RSK2 in pET-28 and pcDNA4 vectors were
performed using a QuickChange
H Lightning site-directed muta-
genesis kit (Stratagene) following the recommended protocol, and
confirmed by DNA sequencing.
Accession Numbers
The refined coordinates of NTD RSK2 and structural factor
data have been deposited in the Protein Data Bank with the access
code 3G51.
Supporting Information
Figure S1 Western blot shows the phosphorylation of the
Ser227 residue in purified proteins (wt NTD, K216A, 50 ng),
crystallized wt NTD, and the absence of phosphorylated Ser227 in
the E118A mutant. Active full length RSK2 (Millipore) was used
as a positive control.
Found at: doi:10.1371/journal.pone.0008044.s001 (0.05 MB TIF)
Figure S2 A general cartoon showing the important interactions
of amino acid residues with AMP-PNP in the active site, as
generated by Ligplot.
Found at: doi:10.1371/journal.pone.0008044.s002 (1.51 MB TIF)
Figure S3 Western blot confirms an equal level of ectopically
expressed proteins - wild type full length RSK2 and K216A
mutant in HEK 293 cells after transfection with 200, 400, or
800 ng. This assay is a complement to the luciferase assay
presented in Figure 8.
Found at: doi:10.1371/journal.pone.0008044.s003 (0.07 MB TIF)
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